about
Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3.Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factorDiabetic heart disease.Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Diabetes and atherogenesis
@ast
Diabetes and atherogenesis
@en
type
label
Diabetes and atherogenesis
@ast
Diabetes and atherogenesis
@en
prefLabel
Diabetes and atherogenesis
@ast
Diabetes and atherogenesis
@en
P2860
P356
P1433
P1476
Diabetes and atherogenesis
@en
P2093
Miles Fisher
P2860
P304
P356
10.1136/HRT.2003.018622
P407
P577
2004-03-01T00:00:00Z